Research Leaders / KOL Map

Lung Cancer (NSCLC): Research Leaders and Landscape

The most active researchers, institutions, and subtopics in Lung Cancer (NSCLC), from recent PubMed records. Public authorship only, every figure verifiable by PMID.

Analyzed 600 recent PubMed papers (2021-2026) matching "non-small cell lung cancer immunotherapy targeted therapy". Source: NLM PubMed. Generated July 2026.

Top research leaders (by recent publication volume)

#ResearcherAffiliationPapers
1Ricciuti BiagioLowe Center for Thoracic Oncology16
2Pecci FedericaLowe Center for Thoracic Oncology11
3Santo ValentinaFondazione Policlinico Universitario Campus Bio-Medico8
4Di Federico AlessandroLowe Center for Thoracic Oncology8
5Cascone TinaThe University of Texas MD Anderson Cancer Center6
6Peters SolangeCentre Hospitalier Universitaire Vaudois6
7Mountzios Giannis4th Department of Medical Oncology and Clinical Trials Uni6
8Cortellini AlessioFondazione Policlinico Universitario Campus Bio-Medico6
9Wu Yi-LongGuangdong Provincial People's Hospital6
10Zhang YanShandong Provincial Qianfoshan Hospital6
11Aldea MihaelaLowe Center for Thoracic Oncology6
12De Giglio AndreaUniversity of Bologna6
13Elkrief ArielleMemorial Sloan Kettering Cancer Center5
14Brunetti LeonardoFondazione Policlinico Universitario Campus Bio-Medico5
15Citarella FabrizioUniversità Campus Bio-Medico di Roma5
16Zhang JianjunThe University of Texas MD Anderson Cancer Center5
17Yu JinmingShandong Cancer Hospital and Institute5
18Gariazzo EleonoraLowe Center for Thoracic Oncology5

Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.

Leading institutions

The University of Texas MD Anderson Cancer Center (18), Shandong Cancer Hospital and Institute (14), Lowe Center for Thoracic Oncology (13), Shanghai Pulmonary Hospital (13), Dana-Farber Cancer Institute (12), Shanghai Chest Hospital (11), West China Hospital (9), Medical Oncology (8), Memorial Sloan Kettering Cancer Center (8), College of Medicine (8)

Active subtopics

Lung Neoplasms (352), Carcinoma, Non-Small-Cell Lung (307), Immunotherapy (147), Immune Checkpoint Inhibitors (98), Tumor Microenvironment (89), Mice (83), Cell Line, Tumor (74), Mutation (60)

Top journals

Frontiers in immunology (32), Frontiers in oncology (30), Translational lung cancer research (19), Cancers (13), Journal for immunotherapy of cancer (13), BMC cancer (10)

Representative recent papers

Copper Induces Antitumor Immune Responses by Triggering Cuproptosis and Immunogenic Cell Death. (2026) · PMID 42476439

Neoadjuvant and perioperative chemo-immunotherapy in early-stage non-small cell lung cancer: international expert panel meeting by (2026) · PMID 42470746

A senescence-associated gene signature predicts radiotherapy prognosis in non-small cell lung cancer and identifies CSF1 as a targ (2026) · PMID 42469881

Gut-lung axis in radiation-induced lung injury: mechanisms and interventions. (2026) · PMID 42465768

Dendritic cells control tertiary lymphoid structure development and maintenance in cancer. (2026) · PMID 42462020

Want the full cited brief?

A full Lung Cancer (NSCLC) brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.

Try the live tool Contact us